PIWORLD Investor Podcasts

Driving the next generation of cell-based medicinesBy Doug Doerfler – Founder, President & CEO
Introduction – 00:23Background and what MaxCyte does - 02:41Business model – 04:11CARMA platform, CAR therapy in oncology - 09:07Cell therapy programmes – business model – 16:12Revenue potential across multiple applications – 19:15Expected news flow - 21:36Summary & outlook – 22:182017 financial highlights - 22:50Q&A - 23:45

Show Notes

Driving the next generation of cell-based medicines
By Doug Doerfler – Founder, President & CEO

Introduction – 00:23
Background and what MaxCyte does - 02:41
Business model – 04:11
CARMA platform, CAR therapy in oncology - 09:07
Cell therapy programmes – business model – 16:12
Revenue potential across multiple applications – 19:15
Expected news flow - 21:36
Summary & outlook – 22:18
2017 financial highlights - 22:50
Q&A - 23:45

Creators and Guests

P
Producer
PIWORLD

What is PIWORLD Investor Podcasts?

Content for investors by investors . These are audio podcast versions of our videos. Sometimes slides are referred to, to view as videos go to www.piworld.co.uk